Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2019 1
2020 3
2021 4
2022 6
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: onoe h. Sci Rep. 2023 May 30;13(1):8747. doi: 10.1038/s41598-023-35759-4. Sci Rep. 2023. PMID: 37253802 Free PMC article.
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: onoe h. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics.
Shijo T, Sakurada Y, Tanaka K, Miki A, Yoneyama S, Machida Y, Chubachi A, Wakatsuki Y, Sugiyama A, Onoe H, Kikushima W, Mori R, Kashiwagi K. Shijo T, et al. Among authors: onoe h. Int J Mol Sci. 2021 Apr 15;22(8):4074. doi: 10.3390/ijms22084074. Int J Mol Sci. 2021. PMID: 33920794 Free PMC article.
Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study.
Tanaka K, Koizumi H, Tamashiro T, Itagaki K, Nakayama M, Maruko I, Wakugawa S, Terao N, Onoe H, Wakatsuki Y, Kasai A, Ogasawara M, Shintake H, Sugano Y, Yamamoto A, Kataoka K, Hasegawa T, Izumi T, Kawai M, Maruko R, Sekiryu T, Okada AA, Iida T, Mori R. Tanaka K, et al. Among authors: onoe h. Jpn J Ophthalmol. 2022 Jul;66(4):379-385. doi: 10.1007/s10384-022-00922-3. Epub 2022 May 21. Jpn J Ophthalmol. 2022. PMID: 35595951
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study.
Tamashiro T, Tanaka K, Itagaki K, Nakayama M, Maruko I, Wakugawa S, Terao N, Onoe H, Wakatsuki Y, Ogasawara M, Sugano Y, Yamamoto A, Kataoka K, Izumi T, Kawai M, Mori R, Sekiryu T, Okada AA, Iida T, Koizumi H; Japan AMD Research Consortium (JARC). Tamashiro T, et al. Among authors: onoe h. Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1857-1865. doi: 10.1007/s00417-021-05517-1. Epub 2022 Jan 16. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35034215
Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study.
Maruko I, Okada AA, Iida T, Hasegawa T, Izumi T, Kawai M, Maruko R, Nakayama M, Yamamoto A, Koizumi H, Tamashiro T, Terao N, Wakugawa S, Mori R, Onoe H, Tanaka K, Wakatsuki Y, Itagaki K, Kasai A, Ogasawara M, Sekiryu T, Shintake H, Sugano Y; Japan AMD Research Consortium. Maruko I, et al. Among authors: onoe h. Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2857-2859. doi: 10.1007/s00417-021-05136-w. Epub 2021 Mar 15. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33723637 Free PMC article. No abstract available.
20 results